Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...

NfL was assessed using the ultrasensitive Simoa and microfluidic Ella platforms and with Lumipulse and Elecsys assays, ...

Regular physical activity slows the accumulation of p-tau181, a key Alzheimer’s biomarker, but its cognitive benefits ...

Simoa is a breakthrough in biomarker detection due to its extremely high sensitivity and specificity. This technology combines single-molecule immunocapture with fluorescence detection, capable of ...